U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Health / Clinical diagnostics

Medical imaging

Search Publications

Search Title, Abstract, Conference, Citation, Keyword or Author
  • Published Date
Displaying 176 - 200 of 229

ToF-SIMS 3D Imaging of Native and Non-Native Species within HeLa Cells

November 26, 2013
Author(s)
Jeremy Brison, Michael A. Robinson, Danielle S. Benoit, Shinichiro Muramoto, Patrick S. Stayton, David G. Castner
In this study, a non-native chemical species, bromodeoxyuridine (BrdU), was imaged within single HeLa cells using time-of-flight secondary ion mass spectrometry (ToF-SIMS). The z-axis corrected 3D images were reconstructed that accurately portray the

Statistical Analysis of Reader Measurement Variability in Nodule Sizing with CT Phantom Imaging Data

November 23, 2012
Author(s)
John Lu, Charles D. Fenimore, Nicholas Petrick, Rongping Zeng, Marios A. Gavrielides, David Clunie, Kristin Borradaile, Robert Ford, Hyun J. Kim, Michael McNitt-Gray, Binsheng Zhao, Andrew Buckler
RSNA has conducted a phantom quantitative imaging biomarker (QIBA) study to assess reader measurement variability of both spherical and non-spherical nodules using CT imaging. Statistical analysis of intra-reader and inter-reader variability of volume

Review: Biological Imaging Software Tools

August 29, 2012
Author(s)
Anne L. Plant, Kevin Eliceiri, Anne Carpenter
Few technologies are more widespread in modern biological laboratories than imaging by microscopy. Advancements in optical technologies and instrumentation over the past twenty years have led to massive improvements in the resolution, specificity

Out-of-plane Stokes imaging polarimeter for early skin cancer diagnosis

July 1, 2012
Author(s)
P. Ghassemi, Paul Lemaillet, Thomas Germer, J. W. Shupp, S. Venna, M. E. Boisvert, K. E. Flanagan, M. H. Jordan, J. C. Ramella-Roman
Optimal treatment of skin cancer before it metastasizes depends critically on early diagnosis and treatment. Imaging spectroscopy and polarized remittance have been utilized in the past for diagnostic purposes, but valuable information can be also obtained

Hyperspectral Imaging of Ischemic Wounds

February 1, 2012
Author(s)
David W. Allen
Optical imaging has the potential to achieve high spatial resolution and high functional sensitivity in wound assessment. However, clinical acceptance of many optical imaging devices is hampered by poor reproducibility, low accuracy, and lack of biological

Controlled transport of superparamagnetic beads with spin-valves

October 7, 2011
Author(s)
Wendy R. Altman, John M. Moreland, Stephen E. Russek, Bruce W. Han, Victor M. Bright
Trapping, release, and transport of individual or ensembles of 2.8 υm superparamagnetic beads functionalized with streptavidin were demonstrated using an addressable and non-volatile array of spin-valve (SV) traps integrated into a microfluidic channel

Tumor volume measurement errors RECIST studied with realistic tumor models

May 16, 2011
Author(s)
Benjamin R. Galloway, Adele Peskin, Zachary H. Levine
RECIST (Response Evaluation Criteria in Solid Tumors) is a linear measure intended to predict tumor volume in medical computed tomography (CT). In this work, using purely geometrical considerations, we estimate how well RECIST can predict the volume of

Reproducibility and Robustness of a Real-Time Microfluidic Cell Toxicity Assay

May 15, 2011
Author(s)
Gregory A. Cooksey, John T. Elliott, Anne L. Plant
Numerous opportunities exist to apply microfluidic technology to high-throughput and high-content cell-based assays. However, maximizing the value of these assays for drug discovery, screening or toxicity evaluation, for example, will require validation of

Data Sets for the Qualification of Volumetric CT as a Quantitative Imaging Biomarker in Lung Cancer

October 20, 2010
Author(s)
Charles D. Fenimore, Andrew Buckler, Lawrence H. Schwartz, Nicholas Petrick, Michael McNitt-Gray, Binsheng Zhao, Anthony P. Reeves, P. David Mozeley, Ricardo S. Avila
The drug development industry is faced with increasing costs and decreasing success rates. New ways to understand biology as well as the increasing interest in personalized treatments for smaller patient segments requires new capabilities for the rapid